Tate & Lyle reported strong customer engagement and early cross-selling success following its CP Kelco combination, with planned synergies on track. However, softer consumer demand has slowed near-term performance, with first-half revenue expected to be 3–4% lower and EBITDA down high-single digits...

Tate & Lyle’s Capital Markets Day showcases its growth strategy, innovation-led portfolio, and the strategic value of CP Kelco, positioning the group at the forefront of food reformulation and nutrition...